Research & Innovation
Maryland-based Altimmune Inc. has submitted an Investigational New Drug application to the U.S. Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal candidate.
The OHDRC Pilot Program facilitates emerging research ideas, explores new methodologies and approaches and facilitates transdisciplinary research as it relates to obesity-related health disparities.
The RADx-UP program is focused on addressing disparities in COVID-19 response in underserved and vulnerable populations.
UAB researchers led a large multiple-country study and used advanced machine learning techniques for risk prediction of neonatal deaths. The study reveals that low weight among newborn infants is associated strongly to most deaths in underdeveloped settings and suggests how these deaths can be reduced.
Alabamians who download and use the GuideSafe™ app now have an added layer of information when traveling to help make smart, informed COVID-19 decisions.
A new multidisciplinary program within UAB Medicine will help evaluate patients who have recovered from COVID-19 but are still experiencing symptoms and link them to the specialized care they need.
The company will focus on the invention, creation and monetization of proprietary medical technologies to solve major health challenges.
This finding and further studies could help treat strabismus, a condition in which the eyes do not properly align with each other while looking at an object.

Investigators are developing a telemedicine program to reduce vaccine hesitancy related to HPV and the novel coronavirus for adolescents in rural Alabama.

To better understand how COVID-19 affects a pregnant woman and her baby, researchers at UAB are enrolling patients in two studies to determine the short- and long-term impacts.
A study conducted by UAB investigators has outlined that deaths due to acute respiratory failure are increasing in the United States, and this disproportionately impacts Southern states and racial minorities.
Funding from the American Heart Association will help promote preventive attitudes regarding cardiovascular health through a virtual campaign.
As the country has grappled with an opioid crisis and with COVID-19, a third crisis has brewed. Suicide is now the 10th leading cause of death in the United States.
The train-the-trainers approach to moving scientific discovery to the marketplace adds 13 more training sites.
One participant said, “It seems like we’ve done 10 years of work in seven months!”
The study suggests that depressive symptoms are a nontraditional risk factor for stroke, something medical professionals need to take into account when talking with their patients.
High-profile speakers show the “critical role that UAB is playing in the effort to combat this pandemic.”
This study used powerful genomic tools and supercomputers to analyze massive amounts of genetic data and identify individual strains within single species of the gut microbiome present during an infant’s first 6 years of life.
A UAB expert investigates Zoom’s security code validation approach for the online safety of users.
The grant will help UAB researchers evaluate the impact of mild traumatic brain injury on teen driving and develop guidelines on when teens can safely get back behind the wheel.
The review of COVID-19 positive case rates and state-wide stay-at-home orders suggests that stay-at-home orders helped reduce transmission of the SARS-CoV-2 virus.
Layers of tannic acid and another biopolymer delay allograft and autoimmune-mediated rejection in mouse models of Type 1 diabetes.
The loss of rural hospitals has been felt most keenly in Southern regions of the United States, from Florida to Texas.
A study conducted by UAB investigators has outlined that Black individuals are disproportionately affected by COVID-19, and there are key geographic differences in health determinants in the United States.
A national report co-written by a UAB dentist found that dentists who were assumed to be at increased risk of COVID exposure had a less than 1 percent infection rate of COVID-19.
A monoclonal antibody is being developed by Aridis Pharmaceuticals as an inhaled, self-administered treatment for non-hospitalized patients who are suffering from mild to moderate COVID-19.
New recommendations for treatment and prevention of HIV infection in adults will help guide physicians and patients in HIV therapies and treatment regimens.
UAB will build an autonomous vehicle mobility facility that works in collaboration with its Engineering and Innovative Technology Development research group.
Integration of the telehealth platform in a multiphase optimization strategy evaluation will allow researchers to develop behavioral health approaches that are more realistic and tailored to the individual’s goals and health needs.
UAB’s new cystic kidney disease core center will spearhead a multidisciplinary approach to finding treatments for this devastating disease
Page 1 of 48